Traditional Chinese medicine for treating restenosis after myocardial infarction operation

A technology of restenosis and traditional Chinese medicine, applied in drug combination, pharmaceutical formulation, cardiovascular system diseases, etc., can solve the problems of expensive drugs, uncertain efficacy, long treatment time, etc., to achieve no toxic side effects, short treatment time, price low cost effect

Inactive Publication Date: 2015-04-22
JILIN UNIV FIRST HOSPITAL
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its medicines are expensive, the curative effect is uncertain, and the treatment time is long, and it is easy to relapse, and some traditional Chinese medicines also have shortcomings such as poor curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine for treating restenosis after myocardial infarction operation
  • Traditional Chinese medicine for treating restenosis after myocardial infarction operation
  • Traditional Chinese medicine for treating restenosis after myocardial infarction operation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] The present invention makes the raw material parts by weight of active ingredient and consists of:

[0018] Radix Paeoniae Alba 10 Radix Pseudostellariae 10 Panax notoginseng 5

[0019] Leech 5 Triangle 5 Curcuma 5

[0020] Gualou 10, Allium 10, Hawthorn 10.

[0021] The preparation method is the same as above.

Embodiment 2

[0023] The present invention makes the raw material parts by weight of active ingredient and consists of:

[0024] Radix Paeoniae Alba 15 Radix Pseudostellariae 15 Panax notoginseng 7

[0025] Leech 7 Triangle 7 Curcuma 7

[0026] Gualou 20, Scallion 20, Hawthorn 25.

[0027] The preparation method is the same as above.

Embodiment 3

[0029] The present invention makes the raw material parts by weight of active ingredient and consists of:

[0030] Radix Paeoniae Alba 25 Radix Pseudostellariae 20 Panax notoginseng 15

[0031] Leech 10 Triangle 10 Curcuma 10

[0032] Gualou 30, Scallion 25, Hawthorn 30.

[0033] The preparation method is the same as above.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A traditional Chinese medicine for treating restenosis after myocardial infarction operation belongs to the traditional Chinese medicine field. The purpose of the invention is to provide a traditional Chinese medicine for treating restenosis after myocardial infarction operation, which is based on traditional Chinese medicine theory, primarily aims at activating blood and dissolving stasis, dredging veins, invigorating qi and warming yang, and secondarily aims at widening chest and benefiting diaphragm, eliminating vexation and dispelling melancholy. Raw materials for preparing effective components of the traditional Chinese medicine of the invention comprise, by weight: white peony roots, radix pseudostellariae, pseudo-ginseng, leeches, rhizoma sparganii, curcuma zedoary, trichosanthes kirilowii maxim, allium macrostemon, and haws. The traditional Chinese medicine of the invention is simple in preparation, low in price, good in curative effect, free of toxic or side effect, short in treatment period, and good in social and economic benefits. The traditional Chinese medicine of the invention is mainly used for treating coronary heart disease, myocardial ischemia, restenosis after myocardial infarction operation, and the like.

Description

Technical field [0001] The invention belongs to the field of Chinese medicine. Background technique [0002] Coronary heart disease, myocardial ischemia, myocardial infarction, uncertainty treatment effect, high recurrence rate, higher mortality, seriously endangering human life.Myocardial infarction belongs to the categories of "chest palsy heartache", "sincere heartache", "heart pain", etc., often occur in middle -aged and elderly people. The cause of the disease is mostly invasive and external;The factors are related.It is the illness of the illness, and its illness, dirty qi deficiency, is the basis of its onset."Li Xiang Polymid" said: "Those who have a heart paralysis, the pulse does not communicate, it hurts if it does not communicate. Traditional Chinese medicine believes that the disease is the testimony of deficiency and qi deficiency and blood stasis. The qi deficiency is an important medicine and pathogenesis that is narrowing againThe internal stop of blood stasis is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P9/10A61K35/62
CPCA61K9/0095A61K35/62A61K36/258A61K36/36A61K36/428A61K36/65A61K36/71A61K36/734A61K36/8962A61K36/902A61K36/9066A61K2300/00
Inventor 张二力杨雪芹许丹董宇翔高霞李有田
Owner JILIN UNIV FIRST HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products